News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AC Immune SA Raises $34.6 Million in Series C


1/28/2009 8:16:17 AM

AC Immune SA, a Swiss drug developer focused on Alzheimer┬┤s disease, has raised CHF 40 million ($34.6m) in Series C funding. No investors were identified, except that they were existing shareholders in the company.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES